Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
PYC Therapeutics Limited ( (AU:PYC) ) has provided an announcement.
PYC Therapeutics Limited has announced a change in the interests of a substantial holder, Australian Land Pty Ltd, and other entities associated with Mr. Alan Tribe. The change, effective from April 23, 2025, reflects a shift in voting power due to a series of entitlement offers and share consolidations. This adjustment in shareholding structure may impact the company’s governance dynamics and influence future strategic decisions.
More about PYC Therapeutics Limited
PYC Therapeutics Limited operates in the biotechnology industry, focusing on developing precision medicines. The company is primarily engaged in creating therapies for genetic disorders, leveraging its expertise in drug development to address unmet medical needs.
YTD Price Performance: -15.02%
Average Trading Volume: 542,662
Technical Sentiment Signal: Hold
Current Market Cap: A$650.3M
For a thorough assessment of PYC stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue